These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36646987)

  • 1. Association between DIO2 Thr92Ala polymorphism and hypertension in patients with hypothyroidism: Korean Genome and Epidemiology Study.
    Kang YM; Koo BS; Yi HS; Kim JT; Park B; Lee JH; Shong M; Kang YE
    Korean J Intern Med; 2023 Mar; 38(2):226-237. PubMed ID: 36646987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type 2 deiodinase Thr92Ala polymorphism is associated with a reduction in bone mineral density: A community-based korean genome and epidemiology study.
    Kang YE; Kang YM; Park B; Shong M; Yi HS
    Clin Endocrinol (Oxf); 2020 Sep; 93(3):238-247. PubMed ID: 32324283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 2 Deiodinase Thr92Ala Polymorphism and Aging Are Associated with a Decreased Pituitary Sensitivity to Thyroid Hormone.
    Luongo C; De Stefano MA; Ambrosio R; Volpe F; Porcelli T; Golia V; Bellevicine C; Troncone G; Masone S; Damiano V; Matano E; Klain M; Schlumberger M; Salvatore D
    Thyroid; 2023 Mar; 33(3):294-300. PubMed ID: 36680751
    [No Abstract]   [Full Text] [Related]  

  • 4. Pathophysiological relevance of deiodinase polymorphism.
    Bianco AC; Kim BS
    Curr Opin Endocrinol Diabetes Obes; 2018 Oct; 25(5):341-346. PubMed ID: 30063552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DIO2 Thr92Ala Reduces Deiodinase-2 Activity and Serum-T3 Levels in Thyroid-Deficient Patients.
    Castagna MG; Dentice M; Cantara S; Ambrosio R; Maino F; Porcelli T; Marzocchi C; Garbi C; Pacini F; Salvatore D
    J Clin Endocrinol Metab; 2017 May; 102(5):1623-1630. PubMed ID: 28324063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterozygote Advantage of the Type II Deiodinase Thr92Ala Polymorphism on Intrahospital Mortality of COVID-19.
    de Lima Beltrão FE; de Almeida Beltrão DC; Carvalhal G; de Lima Beltrão FE; de Souza Braga Filho J; de Brito Oliveira J; de Jesus JDS; Machado GJR; Dos Santos Silva H; Teixeira HMP; Rodrigues JL; de Figueiredo CAV; Dos Santos Costa R; Hecht F; Bianco AC; da Conceição Rodrigues Gonçalves M; Ramos HE
    J Clin Endocrinol Metab; 2022 May; 107(6):e2488-e2501. PubMed ID: 35137147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type 2 deiodinase p.Thr92Ala polymorphism does not affect the severity of obesity and weight loss after bariatric surgery.
    Benenati N; Bufano A; Cantara S; Ricci C; Marzocchi C; Ciuoli C; Sannino I; Tirone A; Voglino C; Vuolo G; Castagna MG
    Sci Rep; 2022 Jun; 12(1):10643. PubMed ID: 35739305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of the common DIO2 Thr92Ala polymorphism and metabolic phenotypes in 7342 Danish white subjects.
    Grarup N; Andersen MK; Andreasen CH; Albrechtsen A; Borch-Johnsen K; Jørgensen T; Auwerx J; Schmitz O; Hansen T; Pedersen O
    J Clin Endocrinol Metab; 2007 Jan; 92(1):363-6. PubMed ID: 17077128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of type II deiodinase polymorphisms in clinical management of hypothyroid patients treated with levothyroxine.
    Al-azzam SI; Alkhateeb AM; Al-Azzeh O; Alzoubi KH; Khabour OF
    Exp Clin Endocrinol Diabetes; 2013 May; 121(5):300-5. PubMed ID: 23329579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No Effect of the Thr92Ala Polymorphism of Deiodinase-2 on Thyroid Hormone Parameters, Health-Related Quality of Life, and Cognitive Functioning in a Large Population-Based Cohort Study.
    Wouters HJ; van Loon HC; van der Klauw MM; Elderson MF; Slagter SN; Kobold AM; Kema IP; Links TP; van Vliet-Ostaptchouk JV; Wolffenbuttel BH
    Thyroid; 2017 Feb; 27(2):147-155. PubMed ID: 27786042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Type 2 Deiodinase Thr92Ala Polymorphism Is Associated with Higher Body Mass Index and Fasting Glucose Levels: A Systematic Review and Meta-Analysis.
    Wang X; Chen K; Zhang C; Wang H; Li J; Wang C; Teng W; Shan Z; Lai Y
    Biomed Res Int; 2021; 2021():9914009. PubMed ID: 34660805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 2 Deiodinase Thr92Ala Polymorphism Is Not Associated with Cognitive Impairment in Older Adults: A Cross-Sectional Study.
    Schwengber WK; Silveira VB; Hetzel GM; Robaina A; Ceolin L; Camelier MT; Goemann I; Dalla Corte RR; Scheffel RS; de Mello RGB; Maia AL; Dora JM
    Metabolites; 2022 Apr; 12(5):. PubMed ID: 35629879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of type 2 iodothyronine deiodinase polymorphism.
    Maino F; Cantara S; Forleo R; Pilli T; Castagna MG
    Expert Rev Endocrinol Metab; 2018 Sep; 13(5):273-277. PubMed ID: 30257587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Physiological Functions and Polymorphisms of Type II Deiodinase.
    Deng Y; Han Y; Gao S; Dong W; Yu Y
    Endocrinol Metab (Seoul); 2023 Apr; 38(2):190-202. PubMed ID: 37150515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ala92 type 2 deiodinase allele increases risk for the development of hypertension.
    Gumieniak O; Perlstein TS; Williams JS; Hopkins PN; Brown NJ; Raby BA; Williams GH
    Hypertension; 2007 Mar; 49(3):461-6. PubMed ID: 17224473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Type II 5' Monodeiodinase Thr92Ala Single Nucleotide Gene Polymorphism and Circulating Thyroid Hormones Among Type 2 Diabetes Mellitus Patients.
    Yalakanti D; Dolia PB
    Indian J Clin Biochem; 2016 Apr; 31(2):152-61. PubMed ID: 27069323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common variation in the DIO2 gene predicts baseline psychological well-being and response to combination thyroxine plus triiodothyronine therapy in hypothyroid patients.
    Panicker V; Saravanan P; Vaidya B; Evans J; Hattersley AT; Frayling TM; Dayan CM
    J Clin Endocrinol Metab; 2009 May; 94(5):1623-9. PubMed ID: 19190113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The rs225017 polymorphism in the 3'UTR of the human DIO2 gene is associated with increased insulin resistance.
    Leiria LB; Dora JM; Wajner SM; Estivalet AA; Crispim D; Maia AL
    PLoS One; 2014; 9(8):e103960. PubMed ID: 25105294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 2 deiodinase polymorphism causes ER stress and hypothyroidism in the brain.
    Jo S; Fonseca TL; Bocco BMLC; Fernandes GW; McAninch EA; Bolin AP; Da Conceição RR; Werneck-de-Castro JP; Ignacio DL; Egri P; Németh D; Fekete C; Bernardi MM; Leitch VD; Mannan NS; Curry KF; Butterfield NC; Bassett JHD; Williams GR; Gereben B; Ribeiro MO; Bianco AC
    J Clin Invest; 2019 Jan; 129(1):230-245. PubMed ID: 30352046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Thr92Ala deiodinase type 2 (DIO2) variant is not associated with type 2 diabetes or indices of insulin resistance in the old order of Amish.
    Mentuccia D; Thomas MJ; Coppotelli G; Reinhart LJ; Mitchell BD; Shuldiner AR; Celi FS
    Thyroid; 2005 Nov; 15(11):1223-7. PubMed ID: 16356084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.